News: Indonesia

Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for…

Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies…

Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga…

Dexa Medica has once again received the prestigious Indonesia Most Reputable Companies Award 2025 from SWA Magazine and Business Digest. This marks the second time Dexa Medica has earned this recognition, reaffirming the company’s commitment to building and maintaining its reputation as a reflection of quality. The award was presented…

Dexa Medica has been awarded the 2025 Industrial Technology Pioneer Award (Rintek) in the category of Technology Pioneer Evaluation Results by the Ministry of Industry of the Republic of Indonesia. The award recognizes the success of Inlacin, an Indonesian Original Modern Medicine for diabetes, as a clinically proven global innovation…

Non-Communicable Diseases such as hypertension, diabetes, and high cholesterol are increasingly threatening public health in Indonesia. According to the Ministry of Health of the Republic of Indonesia, these three silent diseases are among the leading contributors to the national health burden and are often detected only when it is too…

JAKARTA — Strategic and impactful public communication has once again placed Dexa Group on the national stage. The pharmaceutical company has been named Indonesia PR of The Year 2025 by MIX MarComm magazine. The award was presented by MIX MarComm’s Editor-in-Chief, Ms. Lis Hendriani, to Dexa Group’s Head of Corporate…

JAKARTA — Dexa Group’s consistent commitment to sustainability in the pharmaceutical sector has earned the company the Anugerah Ekonomi Hijau (Green Economy Award) from Indonesia national media, detikcom. The award was given in the Green Pharmacy category for the development of Obat Modern Asli Indonesia (OMAI), which combines pharmaceutical innovation…

Karawang, July 20, 2025 — Dexa Medica continues its commitment to public health by hosting another free “Cek Segitiga” health screening program, this time reaching residents at Karangpawitan Field, Karawang on Sunday (July 20, 2025). More than half of the screening participants were found to be at high risk for…

JAKARTA – Stimuno has once again been awarded the Top Brand for Kids Award, a recognition of its long-standing commitment to consistent product quality—from halal assurance to production safety—reflecting Dexa Group’s core value of delivering only the best as the Reflection of Quality. The Top Brand for Kids Award is…